BGI Genomics Co., Ltd. vs NeoGenomics, Inc.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- BGI Genomics Co., Ltd. is the larger company by market value: $2.4 B against $2.2 B for NeoGenomics, Inc., 1.1 times as much (market caps of Aug 1, 2026 for BGI Genomics Co., Ltd. and Oct 15, 2026 for NeoGenomics, Inc.). BGI Genomics Co., Ltd.'s value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.
- BGI Genomics Co., Ltd. had more revenue: $985 M in the year to December 2021 against $727 M for NeoGenomics, Inc. in the year to December 2025.
- BGI Genomics Co., Ltd. made a net profit of $213 M, while NeoGenomics, Inc. made a net loss of $108 M.
- BGI Genomics Co., Ltd. keeps more of each dollar of sales: a net margin of 21.6% against -14.9% for NeoGenomics, Inc.
- BGI Genomics Co., Ltd. employs more people: 3,585 against 2,000 at NeoGenomics, Inc. Each employee brings in about $274,756 of revenue at BGI Genomics Co., Ltd. and $363,665 at NeoGenomics, Inc.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | BGI Genomics Co., Ltd. 300676.SZ · #5,704 in the world | NeoGenomics, Inc. NEO · #6,035 in the world |
|---|---|---|
| Profile | ||
| Country | 🇨🇳 China | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Diagnostics and Research | Diagnostics and Research |
| Founded | 1999 | 2002 |
| Size | ||
| Market cap | $2.4 B | $2.2 B |
| Revenue | $985 M | $727 M |
| Net income | $213 M▲ best | $-108 M |
| Employees | 3,585 | 2,000 |
| Valuation | ||
| P/E ratio | 11.3× | — |
| Price to sales | 2.5× | 2.8× |
| Price to book | 1.8× | 2.6× |
| Free cash flow yield | — | -1.0% |
| Profitability | ||
| Gross margin | — | 43.2% |
| Operating margin | — | -15.9% |
| Net margin | — | -14.8% |
| Return on equity | — | -12.4% |
| Growth | ||
| Revenue growth | — | 10.1% |
| Revenue growth, 3 years a year | — | 12.6% |
| Financial strength | ||
| Debt to equity | — | 0.4× |
| Cash | ||
| Free cash flow margin | — | -3.0% |
| Strength scores | ||
| Piotroski F-score | — | 4 of 9 |
| Altman Z-score zone | — | grey |
| Data as of | Market cap Aug 2026 | Market cap Oct 2026; ratios FY2025 |
Questions and answers#
Which is bigger, BGI Genomics Co., Ltd. or NeoGenomics, Inc.?
BGI Genomics Co., Ltd. is the larger company by market value: $2.4 B against $2.2 B for NeoGenomics, Inc., 1.1 times as much (market caps of Aug 1, 2026 for BGI Genomics Co., Ltd. and Oct 15, 2026 for NeoGenomics, Inc.). BGI Genomics Co., Ltd.'s value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.
Which makes more money, BGI Genomics Co., Ltd. or NeoGenomics, Inc.?
BGI Genomics Co., Ltd. had more revenue: $985 M in the year to December 2021 against $727 M for NeoGenomics, Inc. in the year to December 2025. BGI Genomics Co., Ltd. made a net profit of $213 M, while NeoGenomics, Inc. made a net loss of $108 M.
Which is more profitable, BGI Genomics Co., Ltd. or NeoGenomics, Inc.?
BGI Genomics Co., Ltd. keeps more of each dollar of sales: a net margin of 21.6% against -14.9% for NeoGenomics, Inc.
Which has more employees, BGI Genomics Co., Ltd. or NeoGenomics, Inc.?
BGI Genomics Co., Ltd. employs more people: 3,585 against 2,000 at NeoGenomics, Inc. Each employee brings in about $274,756 of revenue at BGI Genomics Co., Ltd. and $363,665 at NeoGenomics, Inc.